When you're buying income stocks, a company's underlying business is arguably still the most crucial factor to consider, even ...

chief medical officer of the Diabetes Group at Medtronic. "The data demonstrating the benefits of this system are compelling and I'm confident it will simplify diabetes care for both patients and ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

At the intersection of healthcare and technology, medtech companies are leveraging innovative solutions to improve patient ...

The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.

Medtronic executives outlined four categories where the company expects the highest growth from new products in the near term: cardiac ablation, renal denervation, neuromodulation and automated ...

Peralta will be responsible for leading worldwide manufacturing operations, including driving alignment of operations with ...

Medtronic has several products, such as AiBLE (spinal implants) and Percept (brain modulation), that have been getting adopted Its diabetes segment, while the smallest business (about 8% of ...

Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price target of ...

CEOs from Medtronic, Intuitive Surgical, Boston Scientific and Dexcom were on hand this week in San Francisco to discuss the ...

In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Medtronic (MDT – Research Report). The company’s ...